检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Phase 2 trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) for progressive disease after PD-1/PD-L1 immune checkpoint inhibitor (ICI) in metastatic clear cell (mcc) renal cell carcinoma (RCC): Results by independent imaging review and subgroup analyses

Chung-Han Lee,Amishi Yogesh Shah,James J. Hsieh,Arpit Rao,Alvaro Pinto,Mehmet Asim Bilen,Allen Lee Cohn,Christopher Di Simone,David R. Shaffer,Regina Girones Sarrio,Sara Gunnestad Ribe,Jane Wu,Emmett Schmidt,Peter Kubiak,Chinyere Okpara,Alan D. Smith,Louise Young,Robert J. Motzer

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 2|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要